Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs

IMPORTANCE: The Right to Try Act of 2017 allows patients with life-threatening conditions to access investigational medicines outside clinical trials without oversight from the US Food and Drug Administration (FDA). A better understanding of existing expanded access programs can inform the considera...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthumana, Jeremy, Miller, Jennifer E., Kim, Jeanie, Ross, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324420/
https://www.ncbi.nlm.nih.gov/pubmed/30646072
http://dx.doi.org/10.1001/jamanetworkopen.2018.0283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324420/
https://www.ncbi.nlm.nih.gov/pubmed/30646072
http://dx.doi.org/10.1001/jamanetworkopen.2018.0283

Ejemplares similares